Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

April 30, 2007

Conditions
Prostate Cancer
Interventions
DRUG

acetylsalicylic acid

DRUG

dexamethasone

DRUG

diethylstilbestrol

Trial Locations (15)

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

BB10 2PQ

Burnley General Hospital, Burnley

CT2 3NG

Kent and Canterbury Hospital, Canterbury

BN21 2UD

Eastbourne District General Hospital, Eastbourne

E11 1NR

Whipps Cross Hospital, London

EC1A 7BE

Saint Bartholomew's Hospital, London

SW10 9NH

Chelsea Westminster Hospital, London

ME16 9QQ

Maidstone Hospital, Maidstone

MK6 5LD

Milton Keynes General Hospital, Milton Keynes

OX3 7LJ

Churchill Hospital, Oxford

RM7 OBE

Oldchurch Hospital, Romford

TQ2 7AA

Torbay Hospital, Torquay Devon

BS23 4TQ

Weston General Hospital, Weston-super-Mare

BN11 2DH

Worthing Hospital, Worthing

Y031 8HE

Cancer Care Centre at York Hospital, York

All Listed Sponsors
lead

St. Bartholomew's Hospital

OTHER

NCT00316927 - Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter